Therefore, targeting the AIEC virulence determinants specifically involved in triggering IL-23 signaling and in the harmful transdifferentiation of pTh17 cells, as those identified in this study, could represent a promising and unprecedented therapeutic strategy to prevent chronic intestinal inflammation in CD patients. The gene discussed is IL23A; the disease is Cowden disease.